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I
n July this year, China’s Ministry of Health (MoH) com-
missioned an independent external mid-term review 
of progress in its current health system reform (HSR), 
itself designed after unprecedented input from six external 
agencies and the general public (1,2). In its draft report, as 
yet unreleased, the six-member team of eminent reviewers 
praises the leadership and fi-
nancial commitment dem-
onstrated by China’s govern-
ment in pursuing HSR, but 
among other things makes 
strong calls for harmonisa-
tion of urban and rural in-
surance  schemes,  further 
improvements to payment 
mechanisms and oversight 
of the quality of care, quan-
titative evaluations of key systems outputs and health out-
comes and scientific evaluation of the benefit and cost-ef-
fectiveness of traditional Chinese medicine.
The report will be complemented by a formal internal re-
view of the HSR commissioned by China’s State Council. 
Previously such reports have comprised quantitative com-
pilation of the funds allocated, facilities constructed, per-
sonnel trained and deployed, population insured and re-
lated benefits accruing, such as reduced service costs and 
household expenditure on health. This internal review will 
be informed by a “lite” version of China’s five-yearly Na-
tional Health Services Survey (3), focusing less on the for-
mal Survey (next due in 2013) on health status but more 
on operational, funding and implementation issues related 
to the HSR. However, as the external review and a perusal 
of recent published literature makes clear, there is current-
ly little new research upon which to quantitatively assess 
specific outcomes, even those directly benefiting from 
HSR-funded programs such as cancer screening, aged care 
and cataract surgery, partic-
ularly in the absence of re-
lated denominators. 
China’s HSR was a response 
to the deep inequity result-
ing from three decades of 
marketisation and de facto 
privatisation of the health 
sector (4), but despite mas-
sive injection of government 
funds and high uptake of in-
surance, out of pocket expenses for purchase of care remain 
witheringly high for the majority as costs rise (5), and the 
impact of pilot schemes and insurance is uncertain (6,7). 
A large reduction in the proportion of total health expen-
diture that is paid out-of-pocket, from a peak of 60% in 
2001 to 36% in 2010 (Zhao Yuxin, China National Health 
Development Research Centre, personal communication), 
does not prove that population health needs are being met, 
only that government and insurance are funding a bigger 
proportion of services purchased. Although around a half 
of China’s population lives in rural areas, total health ex-
penditure and government allocations heavily favour urban 
areas (8). In addition, the reforms have not tackled the 
The effectiveness and impact of China’s 
health system reform has not yet been ob-
jectively assessed, but government is push-
ing ahead with impressive new initiatives in-
volving village doctors and a computerised 
health management information system that 
should improve availability of data.
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health risks associated with smoking, environmental pol-
lution, urbanisation and China’s aging population – which 
will collectively add hugely to total health expenditure 
(5,9), offsetting the benefits of reform.
Notwithstanding scant objective assessment of progress, 
China’s government is not only moving forward with HSR, 
but expanding its content, ambition and the resources al-
located. China will shortly allocate additional finds to the 
1.4 trillion renminbi (RMB) (around US$ 200 billion, € 150 
billion) already provided (5), including new funds focus-
ing on two of the five reform pillars targeting those most 
disadvantaged by existing inequity – primary health care 
delivery (10) and public health (11). It is no exaggeration 
to say that the government aims to establish, by 2020, a 
system of primary and preventive health care equivalent to 
that which evolved over many decades in developed na-
tions.
Both these areas depend heavily on the front-line health 
workers formerly known as “barefoot doctors”, whose ba-
sic education and training are very low compared to qual-
ified doctors or even public health nurses in most devel-
oped and many developing countries. Indeed, the poor 
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Reliance on implementation and majority 
funding of China’s health reforms by sub-
national authorities and the need for more 
attention to non-communicable disease 
control are major challenges for national 
health leaders.
quality of care and profit motive underlying most medical 
treatment by village doctors in China (4) partially underlies 
another of the five pillars, reform of the national essential 
medicines scheme (12). Recognising their key role, the gov-
ernment is increasingly raising expectations of the role vil-
lage doctors will play. A recent pronouncement by the State 
Council assigns to them roles previously restricted to high-
er levels of the health system (10).
Under the new guidance, village doctors will be expected 
to provide progressively higher quality and standardised 
clinical care within the constraints of China’s new, zero 
profit approach to prescription of essential drugs (12). 
They will also undertake at least the ten basic public health V
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activities (including aged-care, mental health, 
maternal and child health, vaccination and oth-
ers) for which now RMB 25 (US$ 3.9, € 2.9) per 
capita has been allocated across rural China, up 
from RMB 15 (US$ 2.3, € 1.8) at the beginning 
of the HSR in April 2009 (11); participate in 
communicable disease surveillance and the na-
tional notifiable disease reporting system; ad-
minister payments through the cooperative 
medical (insurance) scheme (CMS) and partici-
pate in China’s new computerised health man-
agement and information system (HMIS) (13), 
using networked computers and new software. 
Their payment to implement this impressive list 
of activities will emanate from a combination of 
locally-funded compensation for lost drug in-
come, standardised fees paid by the CMS for 
outpatient services by diagnostic group or capi-
tation (piloting of which is in its earliest stages 
in China), and subsidies taken from the RMB 25 
per capita for implementation of public health 
services. Administration of these various income 
sources will be the responsibility of the county 
health bureau, also charged with ensuring vil-
lage doctors’ qualification, licensing and con-
tinuing education (10).
These monumental changes will bring rural 
health care in China into the 21st century, as be-
fits the nation’s status as a middle-income coun-
try and global economic giant. However, they connote ex-
pectations of diagnostic and therapeutic skill, public health 
competence, computer literacy, community participation 
and also administrative capacity at county level that the 
HSR external reviewers and people familiar with health 
care in rural China know are massively out of step with the 
status quo. In addition, given the State Council’s stated ex-
pectation that supervision of village doctors will be under-
taken by township and county-level professional col-
leagues, and that their funding will be augmented by 
provincial and county resources (10), this modernisation 
of grassroots health care in China should be viewed as a 
generational process.
Does that make it impossible? Only the brave would pre-
dict failure on anything so clearly supported at the highest 
level in modern China, but this brings attention to an old 
theme. In China’s system of policy centralisation with fi-
nancial decentralisation (8), only the highest and most 
politicised national priorities have a strong likelihood of be-
ing implemented at the standard desired, and indeed local 
adaptation of national policy guidelines is encouraged in 
China (14,15). In the health sector, in recent years probably 
only the response to the SARS crisis was pursued with the 
level of priority finally allocated to it by the Chinese gov-
ernment. Most other health policies, recommendations, 
strategies or guidelines including the current HSR rely 
heavily on being prioritised and funded by local leaders, 
and this cannot be assumed. As in most developing nations, 
population health is simply not important enough to many 
local leaders in China, where economic development (ie 
the generation, not the consumption of income) is the main 
objective, especially in poorer areas (5). In addition, where 
private sector regulation is involved the situation becomes 
even more uncertain; for example oversight of food safety 
and the pharmaceutical industry are both very much pri-
oritised by the Ministry of Health, but rely heavily on local 
authorities and the participation of other sectors and inter-
ests (16,17) [witness the ongoing concerns with the dairy 
industry almost three years after the original melamine-
tainting outcry (18,19), and recent drug-, vaccine- and 
food-safety scandals (20–26)]. China’s HSR may be one of 
the highest profile and widely supported government ini-
tiatives of recent years, but the level of reliance on local 
funding and implementation and on other sectors suggests 
its success is not a given. Encouragingly, although substan-
tive, independent assessment of the HSR and including the 
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perspective of citizens is lacking, there are signs of increas-
ing consultation and attention to public opinion in many 
areas of public policy in China (2,27–33), making it hard-
er for local authorities to ignore national priorities. More-
over, China’s massive new online HMIS will record indi-
vidualised data on health status, service uptake and 
payment, insurance participation and benefit, operational 
outputs and population-level health outcomes – all poten-
tially in real-time (13). Failure of local support for HSR will 
thus become increasingly obvious as the HMIS is rolled out. 
What then, of the possibility of an improved and more eq-
uitable health sector in China? In fact, like HSR in most 
nations, the outcome probably depends less on the MoH 
(which understands well the ends and is gradually devis-
ing the means to reach them), than on how other sectors 
and senior planners of China’s socio-economic trajectory 
perceive the importance of population health and equity. 
Whilst China must certainly play catch-up with developed 
nations in regard to educating its health workforce, stan-
dardising quality of care, improving data systems and de-
vising a fair system to fund and pay for services, at least it 
has decades of experience from other nations to draw on 
in these areas. Payment for care is a particular area of dis-
cussion: whilst current initiatives are directing payment to 
providers like hospitals and village doctors, possibly aug-
menting perverse incentives to provide unnecessary care, 
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such as Caesarean section (34), an opposing perspective 
would direct funding toward purchasers of care, whether 
individuals or insurers, to encourage efficiency and quality 
(5,35). This is a complicated issue, but is most definitely a 
focus of the HSR. Much more difficult for China, and cur-
rently lacking attention, will be financing several specific 
health issues: non-communicable disease management and 
control in a population that is both rapidly aging and 
whose lifestyle and diet (beginning in infancy with low 
rates of early and exclusive breastfeeding and poor quality 
complementary food) increase related risk; the impact of 
migration and urbanisation on health outcomes; periodic 
crises arising from the persisting and risky mix of fierce 
competition and lax regulation in areas like food safety and 
the pharmaceutical industry; and risks arising from China’s 
population size and density, which foments new commu-
nicable disease challenges virtually every year. In these ar-
eas, China has far fewer examples to draw on, or where 
solutions exist, they often cannot be reliably implemented. 
It has been said that health care in China became unaf-
fordable for the population, but that HSR might become 
unaffordable for the government (36). Certainly reigning 
in costs and improving efficiency at the same time as re-
ducing health risks, surely an equally important compo-
nent of reforming China’s health sector, presents a formi-
dable constellation of challenges for China’s leaders.  
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